alfuzosin and naftopidil

alfuzosin has been researched along with naftopidil in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Noguchi, Y; Ohtake, A; Sasamata, M; Suzuki, M1
Hoyano, Y; Kobayashi, K; Kobayashi, M; Kuroda, J; Kusama, H; Maruyama, K; Tatemichi, S; Yokoi, R1
Liu, Y; Mao, C; Qin, X; Yang, K; Yang, Z; Yuan, J1
Creta, M; Ficarra, V; Fusco, F; Giannarini, G; Longo, N; Mirone, V; Novara, G; Palmieri, A; Verze, P1
Dahm, P; Jung, JH; Kim, J; Kim, MH; MacDonald, R; Reddy, B1
Miernik, A; Praus, F1

Reviews

4 review(s) available for alfuzosin and naftopidil

ArticleYear
The efficacy and safety of alpha-1 blockers for benign prostatic hyperplasia: an overview of 15 systematic reviews.
    Current medical research and opinion, 2013, Volume: 29, Issue:3

    Topics: Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Humans; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin

2013
α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies.
    European urology, 2016, Volume: 69, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Trials as Topic; Doxazosin; Humans; Indoles; Male; Naphthalenes; Piperazines; Prazosin; Prostatism; Quinazolines; Severity of Illness Index; Sulfonamides; Tamsulosin; Urodynamics

2016
Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    The Cochrane database of systematic reviews, 2017, 11-22, Volume: 11

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quinazolines; Randomized Controlled Trials as Topic; Urological Agents

2017
[LUTS in BPH patients : Comparison of silodosin versus tamsulosin, naftopidil, alfuzosin and placebo for the treatment of lower urinary tract symptoms].
    Der Urologe. Ausg. A, 2019, Volume: 58, Issue:7

    Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quinazolines; Tamsulosin; Treatment Outcome; Urological Agents

2019

Other Studies

2 other study(ies) available for alfuzosin and naftopidil

ArticleYear
In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.
    European journal of pharmacology, 2008, Feb-02, Volume: 580, Issue:1-2

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Dogs; Dose-Response Relationship, Drug; Ejaculation; Indoles; Male; Naphthalenes; Phenylephrine; Piperazines; Prazosin; Pressure; Prostate; Quinazolines; Sulfonamides; Tamsulosin; Urethra; Vas Deferens

2008
Comparison of the effects of four α1-adrenoceptor antagonists on ejaculatory function in rats.
    Urology, 2012, Volume: 80, Issue:2

    Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Ejaculation; Indoles; Male; Naphthalenes; Piperazines; Quinazolines; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamsulosin

2012